HMGA2 as a prognostic and immune biomarker in hepatocellular carcinoma: Comprehensive analysis of the HMG family and experiments validation. Zhong Q, Zhao B, She X, Liu X, et al. PLoS One 2024;19:e0311204.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Zhong Q, Zhao B, She X, Liu X, et al. HMGA2 as a prognostic and immune biomarker in hepatocellular carcinoma: Comprehensive analysis of the HMG family and experiments validation. PLoS One 2024;19:e0311204.
PMID: 39591457